Objective:To investigate the rates of low disease activity and clinical remission in patients with systemic lupus erythematosus(SLE)in a real-world setting,and to analyze the related factors of low disease activity and clinical remission.Methods:One thousand patients with SLE were enrolled from 11 teaching hospitals.Demographic,clinical and laboratory data,as well as treatment regimes were collec-ted by self-completed questionnaire.The rates of low disease activity and remission were calculated based on the lupus low disease activity state(LLDAS)and definitions of remission in SLE(DORIS).Charac-teristics of patients with LLDAS and DORIS were analyzed.Multivariate Logistic regression analysis was used to evaluate the related factors of LLDAS and DORIS remission.Results:20.7％of patients met the criteria of LLDAS,while 10.4％of patients achieved remission defined by DORIS.Patients who met LLDAS or DORIS remission had significantly higher proportion of patients with high income and longer disease duration,compared with non-remission group.Moreover,the rates of anemia,creatinine eleva-tion,increased erythrocyte sedimentation rate(ESR)and hypoalbuminemia was significantly lower in the LLDAS or DORIS group than in the non-remission group.Patients who received hydroxychloroquine for more than 12 months or immunosuppressant therapy for no less than 6 months earned higher rates of LLDAS and DORIS remission.The results of Logistic regression analysis showed that increased ESR,positive anti-dsDNA antibodies,low level of complement(C3 and C4),proteinuria,low household in-come were negatively related with LLDAS and DORIS remission.However,hydroxychloroquine usage for longer than 12 months were positively related with LLDAS and DORIS remission.Conclusion:LLDAS and DORIS remission of SLE patients remain to be improved.Treatment-to-target strategy and standar-dized application of hydroxychloroquine and immunosuppressants in SLE are recommended.

Objective To investigate effect of toll-like receptor 4 (TLR4)/nuclear factor κB (NF-κB) p56 pathway on liver damage in children with rotavirus (RV) enteritis. Methods A total of fifty children with RV enteritis were selected as RV group, while another 50 children with RV negative enteritis during the same period were selected as control group. The levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were measured by automatic biochemical analyzer. TLR4 mRNA and NF-κB mRNA expression in peripheral blood mononuclear cells (PMBC) were detected by polymerase chain reaction (PCR); the expression level of NF-κB p65 protein was detected by Western Blot. The levels of serum AST, ALT and the incidence of liver damage were compared between the two groups. TLR4 mRNA, NF-κB mRNA and NF-κB p65 protein expression in PMBC were compared between the two groups. The expression levels of TLR4 mRNA, NF-κB mRNA and NF-κB p65 protein in PMBC were compared between children with and without liver damage in RV group. The correlation between liver function and TLR4/NF-κB p65 pathway in children with RV enteritis was analyzed by Pearson correlation method. Results The levels of serum AST and ALT as well as the incidence of liver injury in the RV group were significantly higher than those in the control group (P < 0.05). The expressions of TLR4 mRNA, NF-κB mRNA and NF-κB p65 protein of PBMC in the RV group were significantly higher than those in the control group (P < 0.05). In the RV group, the expressions of TLR4 mRNA, NF-κB mRNA and NF-κB p65 protein of PBMC in children with liver damage were significantly higher than those in children without liver damage (P < 0.05). Serum AST and ALT were positively correlated with TLR4 mRNA, NF-κB mRNA and NF-κB p65 protein expression in children with RV enteritis (P < 0.05). Conclusion The incidence of liver damage is higher in children with RV enteritis, which is related to TLR4/NF-κB p65 pathway. Overactivation of TLR4/NF-κB p65 pathway may be one of the causes of liver damage in children with RV enteritis.

Pulmonary blast injury has become the main type of trauma in modern warfare, characterized by externally mild injuries but internally severe injuries, rapid disease progression, and a high rate of early death. The injury is complicated in clinical practice, often with multiple and compound injuries. Currently, there is a lack of effective protective materials, accurate injury detection instrument and portable monitoring and transportation equipment, standardized clinical treatment guidelines in various medical centers, and evidence-based guidelines at home and abroad, resulting in a high mortality in clinlcal practice. Therefore, the Trauma Branch of Chinese Medical Association and the Editorial Committee of Chinese Journal of Trauma organized military and civilian experts in related fields such as thoracic surgery and traumatic surgery to jointly develop the Clinical treatment guideline for pulmonary blast injury ( version 2023) by combining evidence for effectiveness and clinical first-line treatment experience. This guideline provided 16 recommended opinions surrounding definition, characteristics, pre-hospital diagnosis and treatment, and in-hospital treatment of pulmonary blast injury, hoping to provide a basis for the clinical treatment in hospitals at different levels.